608 related articles for article (PubMed ID: 16162991)
21. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
Santos AM; da Rocha MS; da Silva MF
Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
[TBL] [Abstract][Full Text] [Related]
23. A jaundiced bodybuilder Cholestatic hepatitis as side effect of injectable anabolic-androgenic steroids.
Boks MN; Tiebosch AT; van der Waaij LA
J Sports Sci; 2017 Nov; 35(22):2262-2264. PubMed ID: 27937337
[TBL] [Abstract][Full Text] [Related]
24. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.
Solbach P; Potthoff A; Raatschen HJ; Soudah B; Lehmann U; Schneider A; Gebel MJ; Manns MP; Vogel A
BMC Gastroenterol; 2015 May; 15():60. PubMed ID: 25986067
[TBL] [Abstract][Full Text] [Related]
25. Anabolic steroid-induced hepatotoxicity: is it overstated?
Dickerman RD; Pertusi RM; Zachariah NY; Dufour DR; McConathy WJ
Clin J Sport Med; 1999 Jan; 9(1):34-9. PubMed ID: 10336050
[TBL] [Abstract][Full Text] [Related]
26. Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders.
Fineschi V; Riezzo I; Centini F; Silingardi E; Licata M; Beduschi G; Karch SB
Int J Legal Med; 2007 Jan; 121(1):48-53. PubMed ID: 16292586
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis?
Pertusi R; Dickerman RD; McConathy WJ
J Am Osteopath Assoc; 2001 Jul; 101(7):391-4. PubMed ID: 11476029
[TBL] [Abstract][Full Text] [Related]
28. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents.
Bahrke MS; Yesalis CE; Brower KJ
Child Adolesc Psychiatr Clin N Am; 1998 Oct; 7(4):821-38. PubMed ID: 9894044
[TBL] [Abstract][Full Text] [Related]
29. Trends in anabolic-androgenic steroid use among adolescents.
Yesalis CE; Barsukiewicz CK; Kopstein AN; Bahrke MS
Arch Pediatr Adolesc Med; 1997 Dec; 151(12):1197-206. PubMed ID: 9412594
[TBL] [Abstract][Full Text] [Related]
30. Body image, disordered eating and anabolic steroid use in female bodybuilders.
Goldfield GS
Eat Disord; 2009; 17(3):200-10. PubMed ID: 19391019
[TBL] [Abstract][Full Text] [Related]
31. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States.
DuRant RH; Escobedo LG; Heath GW
Pediatrics; 1995 Jul; 96(1 Pt 1):23-8. PubMed ID: 7596717
[TBL] [Abstract][Full Text] [Related]
32. [Estimated consumption of anabolic steroids among athletes in Denmark].
Fauner M; Kisling A; Nielsen SL
Nord Med; 1995; 110(1):23-5. PubMed ID: 7831105
[TBL] [Abstract][Full Text] [Related]
33. Dietary influences on cardiovascular disease risk in anabolic steroid-using and nonusing bodybuilders.
Kleiner SM; Calabrese LH; Fiedler KM; Naito HK; Skibinski CI
J Am Coll Nutr; 1989 Apr; 8(2):109-19. PubMed ID: 2708728
[TBL] [Abstract][Full Text] [Related]
34. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
35. Anabolic steroid use by athletes. How serious are the health hazards?
Windsor RE; Dumitru D
Postgrad Med; 1988 Sep; 84(4):37-8, 41-3, 47-9. PubMed ID: 3420049
[TBL] [Abstract][Full Text] [Related]
36. ACOG Committee Opinion No. 484: Performance enhancing anabolic steroid abuse in women.
Obstet Gynecol; 2011 Apr; 117(4):1016-1018. PubMed ID: 21422881
[TBL] [Abstract][Full Text] [Related]
37. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.
Kanayama G; DeLuca J; Meehan WP; Hudson JI; Isaacs S; Baggish A; Weiner R; Micheli L; Pope HG
Am J Sports Med; 2015 Nov; 43(11):2638-44. PubMed ID: 26362436
[TBL] [Abstract][Full Text] [Related]
38. Are anabolic-androgenic steroid users polysubstance users?
Dunn M
J Sci Med Sport; 2009 Nov; 12(6):e1-2. PubMed ID: 19119065
[No Abstract] [Full Text] [Related]
39. [Cardiovascular alterations associated with doping].
Thieme D; Büttner A
Herz; 2015 May; 40(3):410-6. PubMed ID: 25828698
[TBL] [Abstract][Full Text] [Related]
40. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
